Nurix Therapeutics: Truist Securities cuts target price to $33 from $34
NRIX•Truist Securities cut its target price for Nurix Therapeutics to $33 from $34.
Related News
Ball Corp: RBC cuts target price to $73 from $77
BALL•
Applied Materials unveils $5 billion Epic Center in Silicon Valley for AI-era semiconductor innovation
AMAT•
Saudi capital's airport to remain shut this week as airlines cancel services
DAL•
Credo teams with optical suppliers to launch OCP SRMO standards workstream
CRDO•
Jardine Matheson lifts 2026 underlying earnings guidance to US$5.50-US$5.65 per share
JMHLY•